Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

Jozefien Declercq; Karel F A Van Damme; Elisabeth De Leeuw; Bastiaan Maes; Cedric Bosteels; Simon J Tavernier; Stefanie De Buyser; Roos Colman; Maya Hites; Gil Verschelden; Tom Fivez; Filip Moerman; Ingel K Demedts; Nicolas Dauby; Nicolas De Schryver; Elke Govaerts; Stefaan J Vandecasteele; Johan Van Laethem; Sebastien Anguille; Jeroen van der Hilst; Benoit Misset; Hans Slabbynck; Xavier Wittebole; Fabienne Liénart; Catherine Legrand; Marc Buyse; Dieter Stevens; Fre Bauters; Leen J M Seys; Helena Aegerter; Ursula Smole; Victor Bosteels; Levi Hoste; Leslie Naesens; Filomeen Haerynck; Linos Vandekerckhove; Pieter Depuydt; Eva van Braeckel; Sylvie Rottey; Isabelle Peene; Catherine Van Der Straeten; Frank Hulstaert; Bart N Lambrecht

The Lancet. Respiratory medicine (2021) - Comments
doi: 10.1016/s2213-2600(21)00377-5 issn: 2213-2600 pubmed: 34756178 issn: 2213-2619

Jozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cedric Bosteels, Simon J Tavernier, Stefanie De Buyser, Roos Colman, Maya Hites, Gil Verschelden, Tom Fivez, Filip Moerman, Ingel K Demedts, Nicolas Dauby, Nicolas De Schryver, Elke Govaerts, Stefaan J Vandecasteele, Johan Van Laethem, Sebastien Anguille, Jeroen Van Der Hilst